Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipopolysaccharide lipid A phosphate is a fundamental structural component of the outer membrane of Gram-negative bacteria, serving as the hydrophobic anchor for the lipopolysaccharide (LPS) molecule [2]. It typically consists of a glucosamine disaccharide backbone with attached fatty acid chains and negatively charged phosphate groups at the 1 and 4' positions [2]. These phosphate groups are vital for maintaining the structural integrity of the bacterial cell wall by forming ionic bridges with divalent cations such as Mg2+ and Ca2+ [1]. This anionic nature makes lipid A phosphate the primary target for cationic antimicrobial peptides and polymyxin antibiotics, which displace the stabilizing cations to disrupt the membrane [1, 5]. Clinically, lipid A is known as an endotoxin because its recognition by the Toll-like receptor 4 (TLR4) complex triggers a robust inflammatory response [4]. Excessive activation of this pathway during systemic Gram-negative infections can lead to life-threatening conditions such as sepsis and septic shock [4]. Bacterial resistance to drugs targeting this site often involves the covalent modification of the phosphate groups (e.g., with phosphoethanolamine) to reduce their negative charge, a process often mediated by the mcr-1 gene [3]. Sources: [1] Nature Reviews Microbiology, 'Polymyxins: antibacterial mechanism of action and resistance', 2019; [2] Journal of Biological Chemistry, 'The enzymatic pathway of lipid A biosynthesis', 2009; [3] The Lancet Infectious Diseases, 'Emergence of plasmid-mediated colistin resistance mechanism MCR-1', 2016; [4] Frontiers in Immunology, 'Lipopolysaccharide Recognition, Response and Pathway', 2020; [5] StatPearls, 'Polymyxin B', 2023.
Cationic antibiotics, specifically polymyxins, exert their effect through an initial electrostatic interaction between their positively charged residues and the negatively charged phosphate groups of lipid A [1]. This interaction leads to the displacement of divalent cations (calcium and magnesium) that normally stabilize the outer membrane [5]. Consequently, the outer membrane is weakened, allowing the drug to penetrate and further disrupt the inner membrane, leading to the leakage of cytoplasmic contents and bacterial cell death [1].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide lipid A phosphate (Lipid A phosphate).